Breaking the 5-year barrier: results from the MA.17 extended adjuvant trial in women who have completed adjuvant tamoxifen treatment
Goss PE. Breaking the 5-year barrier: results from the MA.17 extended adjuvant trial in women who have completed adjuvant tamoxifen treatment. European Journal of Cancer Supplements 4(9) -
Proceedings of the satellite symposium ’The quiet revolution in breast cancer treatment: how aromatase inhibitors are displacing tamoxifen’. 2006; 4, Issue 9:10-15.